Clinical Trial Details
EORTC-62002
Back to Clinical Trials Database
Phase I study to determine the safety of Caelyx (Doxorubicin HCI, pegylated liposomal) in combination with Ifosfamide in previously untreated adult patients with advanced and/or metastatic soft tissues sarcomas.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 06-Nov-2001 Date Step1 close: 30-Mar-2005 |
| Data management at EORTC | Yes |
| Design |
Phase 1 Randomized open label |
| Targeted Sample size | EORTC Groups: 40 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00030784 |
| NCT number | NCT00030784 |
